Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells

Current therapies for prostate cancer include antiandrogens, inhibitory ligands of the androgen receptor, which repress androgen-stimulated growth. These include the selective androgen receptor modulators cyproterone acetate and hydroxyflutamide and the complete antagonist bicalutamide. Their activi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Cell Proteomics
Autori principali: Brooke, Greg N., Gamble, Simon C., Hough, Michael A., Begum, Shajna, Dart, D. Alwyn, Odontiadis, Michael, Powell, Sue M., Fioretti, Flavia M., Bryan, Rosie A., Waxman, Jonathan, Wait, Robin, Bevan, Charlotte L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: The American Society for Biochemistry and Molecular Biology 2015
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4424393/
https://ncbi.nlm.nih.gov/pubmed/25693800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M113.036764
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi